Henry Schein stock is trading -7.61% below its average target price of $77.09 after marking a 5.4% during today's morning session. Analysts are giving the Mid-Cap Medical Specialities company an average rating of hold and target prices ranging from $60.0 to $92.0 per share.
Henry Schein has an average level of shares sold short, at 5.1% of its total share float. The stock's short ratio (also called days to cover) is 5.41. Only 0.89% of the company's shares are owned by insiders, indicating that management does not have a deep alignment of interest with its shareholders.
Institutional investors own 101.3% of Henry Schein's shares, which indicates they have a high level of confidence in the company.
Institutions Invested in Henry Schein
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-03-31 | Vanguard Group Inc | 12% | 15,432,001 | $1,099,067,130 |
| 2024-03-31 | Generation Investment Management LLP | 8% | 10,134,037 | $721,746,127 |
| 2024-03-31 | Blackrock Inc. | 8% | 9,799,769 | $697,939,560 |
| 2024-03-31 | State Street Corporation | 5% | 6,388,925 | $455,019,246 |
| 2024-03-31 | Invesco Ltd. | 5% | 6,262,521 | $446,016,753 |
| 2024-03-31 | Artisan Partners Limited Partnership | 5% | 6,067,774 | $432,146,871 |
| 2024-03-31 | American Century Companies Inc | 4% | 5,321,809 | $379,019,243 |
| 2024-03-31 | JP Morgan Chase & Company | 4% | 5,156,354 | $367,235,538 |
| 2024-03-31 | Geode Capital Management, LLC | 2% | 3,160,317 | $225,077,780 |
| 2024-03-31 | Swedbank | 2% | 2,860,141 | $203,699,245 |
